[1]吴 薇,吴 洁,武金玉,等. 肝转移癌射频消融治疗方案制定——超声造影的应用价值[J].介入放射学杂志,2014,(06):487-490.
 WU Wei,WU Jie,WU Jin- yu,et al. Application value of contrast- enhanced ultrasonography in managing liver metastases before percutaneous radiofrequency ablation treatment[J].journal interventional radiology,2014,(06):487-490.
点击复制

 肝转移癌射频消融治疗方案制定——超声造影的应用价值()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2014年06期
页码:
487-490
栏目:
非血管介入
出版日期:
2014-07-05

文章信息/Info

Title:
 Application value of contrast- enhanced ultrasonography in managing liver metastases before percutaneous radiofrequency ablation treatment
作者:
 吴 薇 吴 洁 武金玉 严 昆 杨 薇 李荣杰 张仲一 陈敏华
Author(s):
 WU Wei WU Jie WU Jin- yu YAN Kun YANG Wei LEE Jung- chieh ZHANG Zhong- yi CHEN Min- hua.
 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Ultrasound, Peking University School Of Oncology, Beijing Cancer Hospital & Institute, Beijing 100142, China
关键词:
 【关键词】 超声检查 对比剂 肝转移癌 消融术
文献标志码:
A
摘要:
 【摘要】 目的 探讨超声造影(CEUS)在肝转移癌经皮射频消融(RFA)治疗前的应用价值。方法 2001年7月—2012年12月期间经皮RFA治疗的肝转移癌共267例485灶为本研究对象。其中180例251灶RFA治疗前行CEUS检查并确定RFA治疗方案(CEUS组),另87例234灶为RFA治疗前未行CEUS检查(对照组)。两组病例的各项临床资料差异均无统计学意义(P < 0.05)。治疗后采用增强CT或(和)MRI、CEUS及肿瘤标志物检查定期随访判断疗效。结果 CEUS组中,25.1%(63/251灶)的CEUS测值较常规超声增大3 mm以上;8.8%(22/251灶)CEUS后显示清晰;造影后发现新病灶41灶。RFA治疗后,肿瘤早期灭活率CEUS组与对照组分别为95.2%(239/251灶)、92.7%(217/234灶),差异无统计学意义(P > 0.05)。局部复发率CEUS组低于对照组,分别为12.4%(31/251)、19.7%(46/234)(P < 0.05)。局部复发时间CEUS组与对照组差异无统计学意义(P > 0.05)。结论 肝转移癌经皮RFA治疗前行CEUS检查有助于准确判断病灶大小及数目,制订有效治疗方案,从而提高肿瘤早期灭活率、降低复发新生率。

参考文献/References:

 [1] 房星宇, 于 淼, 杨倚天, 等. 肝动脉化疗栓塞及射频消融治疗胰腺神经内分泌肿瘤肝转移的疗效和生存分析[J]. 介入放射学杂志, 2013, 22: 377 - 380.
[2] Meloni MF, Andreano A, Laeseke PF, et al. Breast Cancer liver metastases: US- guided percutaneous radiofrequency ablation—intermediate and long- term survival rates[J]. Radiology, 2009, 253: 861 - 869.
[3] Jin Y, Cai YC, Cao Y, et al. Radiofrequency ablation combined with systemic chemotherapy in nasopharyngeal carcinoma liver metastases improves response to treatment and survival outcomes[J]. J Surg Oncol, 2012, 106: 322 - 326.
[4] 彭国文, 李晓群. 射频消融及组合方案治疗特殊/高危部位肝癌的中远期疗效[J]. 介入放射学杂志, 2013, 22: 525 - 528.
[5] Dai Y, Chen MH, Fan ZH, et al. Diagnosis of small hepatic nodules detected by surveillance ultrasound in patients with cirrhosis: Comparison between contrast- enhanced ultrasound and contrast- enhanced helical computed tomography[J]. Hepatol Res, 2008, 38: 281 - 290.
[6] Wen YL, Kudo M, Zheng RQ, et al. Characterization of hepatic tumors: value of contrast- enhanced coded phase- inversion harmonic angio[J]. AJR, 2004, 182: 1019 - 1026.
[7] Zheng YL, Yin XY, Xie XY, et al. Value of contrast- enhanced ultrasonography in assessing the vascularity of liver metastases: comparison with contrast- enhanced computed tomography[J]. J Ultrasound Med, 2010, 29: 1403 - 1410.
[8] Solbiati L, Tonolini M, Cova L. Monitoring RF ablation[J]. Eur Radiol, 2004, 14: P34 - P42.
[9] Minami Y, Kudo M, Kawasaki T, et al. Treatment of hepato- cellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B- mode sonography[J]. AJR, 2004, 183: 153 - 156.
[10] Solbiati L, Ierace T, Tonolini M, et al. Guidance and control of percutaneous treatments with contrast- enhanced ultrasound[J]. Eur Radiol, 2003, 13: N87 - N90.
[11] Kim CK, Choi D, Lim HK, et al. Therapeutic response assess- ment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast- enhanced agent detection imaging[J]. Eur J Radiol, 2005, 56: 66 - 73.
[12] Chen MH, Yang W, Yan K, et al. The role of contrast- enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation[J]. Clin Radiol, 2007, 62: 752 - 760.
[13] Chen MH, Wu W, Yang W, et al. The use of contrast- enhanced ultrasonography in the selection of patients with hepatocellular carcinoma for radio frequency ablation therapy[J]. J Ultrasound Med, 2007, 26: 1055 - 1063.
[14]武金玉, 陈敏华, 严 昆, 等. 超声造影对肝转移癌射频消融的应用价值[J]. 中华超声影像学杂志, 2008, 17: 307 - 311.
[15] Chen MH, Yang W, Yan K, et al. Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients—mathematic model, overlapping mode, and electrode placement process[J]. Radiology, 2004, 232: 260 - 271.
[16] Gillams AR, Lees WR. Five- year survival following radiofre- quency ablation of small, solitary, hepatic colorectal metastases[J]. J Vasc Interv Radiol, 2008, 19: 712 - 717.
[17] Sorensen SM, Mortensen FV, Nielsen DT. Radiofrequency ablation of colorectal liver metastases: long- term survival[J]. Acta radiol, 2007, 48: 253 - 258.
[18] Wu J, Yang W, Yin S, et al. Role of contrast- enhanced ultrasonography in percutaneous radiofrequency ablation of liver metastases and efficacy evaluation[J]. Chin J Cancer Res, 2013, 25: 143 - 154.

相似文献/References:

[1]张 琳,黄学全,王健,等.自主研发电化学治疗同轴电极与传统针式电极电解效应的对比研究[J].介入放射学杂志,2012,(02):148.
 ZHANG Lin,HUANG Xue-quan,WANG Jian,et al.The electrolytic effect in electrochemotherapy: a comparative study between self-prepared coaxial electrode and conventional needle electrode[J].journal interventional radiology,2012,(06):148.
[2]赵 玮,王伟中,陈莹,等.耳部动静脉畸形供血动脉的血管造影研究[J].介入放射学杂志,2012,(02):103.
 ZHAO Wei,WANG Wei-zhong,CHEN Ying,et al.Angiographic findings of the feeding arteries of auricular arteriovenous malformations[J].journal interventional radiology,2012,(06):103.
[3]邹俊民,龙世娟,张振明. 改良髂内动脉化疗联合放疗治疗Ⅲ~Ⅳa期 子宫颈癌32例[J].介入放射学杂志,2012,(02):123.
 ZOU Jun-min,LONG Shi-Juan,ZHANG Zheng-ming..Improved internal iliac artery chemotherapy combined with radiotherapy for the treatment of stage Ⅲ-Ⅳa cervical cancers[J].journal interventional radiology,2012,(06):123.
[4]王昌明,李 选,宋世兵,等.肝门部胆道引流管折叠技术在肝移植后胆道非吻合口狭窄治疗中的应用[J].介入放射学杂志,2012,(02):136.
 WANG Chang-ming,LI Xuan,SONG Shi-bing,et al.The application of biliary catheter folding technique in the treatment of hilar nonanastomotic biliary strictures after orthotopic liver transplantation[J].journal interventional radiology,2012,(06):136.
[5]赵玉峰,孙玉琴,韩晓静,等. 输卵管介入再通术后受孕时机的研究[J].介入放射学杂志,2012,(02):158.
 ZHAO Yu-feng,SUN Yu-qin,HAN Xiao-jing,et al.The optimal time for conception after fallopian tube recanalization therapy[J].journal interventional radiology,2012,(06):158.
[6]含 笑,曹建民,史东宏,等.吉西他滨、顺铂动静脉联合化疗治疗晚期非小细胞肺癌的近期疗效分析[J].介入放射学杂志,2012,(02):119.
 HAN Xiao,CAO Jian-min,SHI Dong-hong,et al.Bronchial artery infusion of Gemcitabine and Cisplatin combined with systemic chemotherapy for advanced non-small cell lung cancer: its short-term efficacy[J].journal interventional radiology,2012,(06):119.
[7]姚雪松,李 槐.不可手术切除的肝细胞癌的疗效评价标准——改良RECIST标准更可靠[J].介入放射学杂志,2012,(03):177.
 . Therapeutic evaluation criterion of inoperable hepatocellular carcinomas: modified RECIST as a more reliable standard[J].journal interventional radiology,2012,(06):177.
[8]齐 立,李慎茂,俸军林,等. 动脉溶栓与机械碎栓联合动脉溶栓的对比分析[J].介入放射学杂志,2012,(03):180.
 ,,et al. Comparison of the therapeutic efficacy between simple arterial thrombolysis and mechanical thrombectomy combined with arterial thrombolysis for acute cerebral infarction at its ultraearly stage[J].journal interventional radiology,2012,(06):180.
[9]石 潆,赵 卫,沈 进,等.脑动静脉畸形栓塞治疗术并发颅内出血的原因及处理[J].介入放射学杂志,2012,(03):185.
 ,,et al.Intracranial hemorrhage due to embolization therapy for cerebral arteriovenous malformation: its causes and management [J].journal interventional radiology,2012,(06):185.
[10]周 慷,李晓光,金征宇,等.清宫术前子宫动脉化疗栓塞术治疗瘢痕妊娠的疗效分析[J].介入放射学杂志,2012,(03):190.
 ,,et al.Therapeutic analysis of bilateral uterine artery chemoembolization performed before uterine dilation and curettage for cesarean scar pregnancy [J].journal interventional radiology,2012,(06):190.
[11]严 昆,陈敏华,李荣杰,等. 残留复发性肝肿瘤射频消融治疗——超声造影的应用价值[J].介入放射学杂志,2014,(06):496.
 YAN Kun,CHEN Min- hua,LEE Jung- chieh,et al. The clinical application of contrast enhanced ultrasonography in radiofrequency ablation therapy for residual and recurrent hepatic neoplasms[J].journal interventional radiology,2014,(06):496.

备注/Memo

备注/Memo:
 (收稿日期:2014-03-03)
更新日期/Last Update: